Show simple item record

dc.contributor.authorWaldman, Benjamin S
dc.contributor.authorSchwarz, Dominic
dc.contributor.authorWadsworth, Marc H
dc.contributor.authorSaeij, Jeroen P
dc.contributor.authorShalek, Alex K
dc.contributor.authorLourido, Sebastian
dc.date.accessioned2021-10-27T20:34:33Z
dc.date.available2021-10-27T20:34:33Z
dc.date.issued2020
dc.identifier.urihttps://hdl.handle.net/1721.1/136258
dc.description.abstract© 2019 The Author(s) Toxoplasma gondii chronically infects a quarter of the world's population, and its recrudescence can cause life-threatening disease in immunocompromised individuals and recurrent ocular lesions in the immunocompetent. Acute-stage tachyzoites differentiate into chronic-stage bradyzoites, which form intracellular cysts resistant to immune clearance and existing therapies. The molecular basis of this differentiation is unknown, despite being efficiently triggered by stresses in culture. Through Cas9-mediated screening and single-cell profiling, we identify a Myb-like transcription factor (BFD1) necessary for differentiation in cell culture and in mice. BFD1 accumulates during stress and its synthetic expression is sufficient to drive differentiation. Consistent with its function as a transcription factor, BFD1 binds the promoters of many stage-specific genes and represents a counterpoint to the ApiAP2 factors that dominate our current view of parasite gene regulation. BFD1 provides a genetic switch to study and control Toxoplasma differentiation and will inform prevention and treatment of chronic infections.
dc.language.isoen
dc.publisherElsevier BV
dc.relation.isversionof10.1016/J.CELL.2019.12.013
dc.rightsCreative Commons Attribution 4.0 International license
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceElsevier
dc.titleIdentification of a Master Regulator of Differentiation in Toxoplasma
dc.typeArticle
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biology
dc.contributor.departmentWhitehead Institute for Biomedical Research
dc.contributor.departmentMassachusetts Institute of Technology. Institute for Medical Engineering & Science
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemistry
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MIT
dc.contributor.departmentRagon Institute of MGH, MIT and Harvard
dc.relation.journalCell
dc.eprint.versionFinal published version
dc.type.urihttp://purl.org/eprint/type/JournalArticle
eprint.statushttp://purl.org/eprint/status/PeerReviewed
dc.date.updated2020-09-21T14:13:16Z
dspace.orderedauthorsWaldman, BS; Schwarz, D; Wadsworth, MH; Saeij, JP; Shalek, AK; Lourido, S
dspace.date.submission2020-09-21T14:13:25Z
mit.journal.volume180
mit.journal.issue2
mit.licensePUBLISHER_CC
mit.metadata.statusAuthority Work and Publication Information Needed


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record